THRM vs WOOF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
THRM presents a contradictory profile: a stable balance sheet paired with deteriorating earnings performance. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $29.58 trades at a significant premium to both the Graham Number ($17.7) and the growth-based Intrinsic Value ($4.13). While the Forward P/E of 9.58 suggests a massive expected earnings recovery, the current YoY earnings crash of -81.20% and a bearish technical trend create significant near-term risk. The investment thesis relies entirely on a turnaround in profitability that has not yet materialized in the data.
WOOF presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a current price ($2.99) that significantly exceeds both its Graham Number ($1.67) and Intrinsic Value ($0.21). The company is struggling with negative revenue growth (-2.40%) and razor-thin profit margins (0.15%), indicating a lack of pricing power or rising operational costs. Financial health is precarious, evidenced by a high Debt/Equity ratio of 2.48 and a critically low Quick Ratio of 0.27. While analysts maintain a 'Hold' rating with a target of $3.52, the combination of bearish insider sentiment and a 0/100 technical trend suggests strong downward pressure.
Compare Another Pair
Related Comparisons
THRM vs WOOF: Head-to-Head Comparison
This page compares Gentherm Incorporated (THRM) and Petco Health and Wellness Company, Inc. (WOOF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.